Intravitreal bevacizumab versus panretinal photocoagulation for treatment-naïve proliferative and severe nonproliferative diabetic retinopathy

Acta Ophthalmologica

Volumn 90, Issue 7, 2012, Pages

  Ernst, Benjamin J ^a   García Aguirre, Gerardo ^b   Oliver, Scott C N ^c   Olson, Jeffrey L ^c   Mandava, Naresh ^c   Quiroz Mercado, Hugo ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b Asociacion para Evitar la Ceguera en Mexico IAP   (Mexico)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB;

BEST CORRECTED VISUAL ACUITY; CENTRAL MACULAR THICKNESS; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DIABETIC RETINOPATHY; DRUG EFFECT; DRUG EFFICACY; ENDOPHTHALMITIS; EYE SURGERY; FLUORESCENCE ANGIOGRAPHY; HUMAN; INTERMETHOD COMPARISON; LASER COAGULATION; LETTER; NEOVASCULARIZATION (PATHOLOGY); OPHTHALMOLOGY; OPTICAL COHERENCE TOMOGRAPHY; PANRETINAL PHOTOCOAGULATION; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REMISSION; RETINA DETACHMENT; RETINA MACULA EDEMA; RETINA MACULOPATHY; TRACTIONAL RETINAL DETACHMENT; TREATMENT DURATION; TREATMENT RESPONSE; VISUAL ACUITY; VISUAL IMPAIRMENT;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INTRAVITREAL INJECTIONS; LASER COAGULATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETINAL NEOVASCULARIZATION; RETREATMENT; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 84868212116     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2011.02364.x     Document Type: Letter

References (4)

1. Early Treatment Diabetic Retinopathy Study Research Group (1991): Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Ophthalmology 98: 766-785.
2. Mason JO III, Yunker JJ, Vail R, &, McGwin G Jr, (2008): Intravitreal bevacizumab (Avastin) prevention of panretinal photocoagulation-induced complications in patients with severe proliferative diabetic retinopathy. Retina 28: 1319-1324.
3. McDonald HR, &, Schatz H, (1985): Visual loss following panretinal photocoagulation for proliferative diabetic retinopathy. Ophthalmology 92: 388-393. (Pubitemid 15099102)
4. Tonello M, Costa RA, Almeida FP, Barbosa JC, Scott IU, &, Jorge R, (2008): Panretinal photocoagulation versus PRP plus intravitreal bevacizumab for high-risk proliferative diabetic retinopathy (IBeHi study). Acta Ophthalmol 86: 385-389.